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main products of copper and lead, the company, Boliden Mineral AB, operates plants for the recovery of precious metals, special products, and sulphur products from the raw materials. The processes have mostly been developed within the company.
In the production of lead, the smelter primarily uses lead concentrates from the company, and also flue dust containing lead obtained as a byproduct from the company's plant for the production of copper and zinc concentrates. Flash smelting is used for the production of lead. The concentrate is smelted in an electric furnace without previous roasting or sintering, and the furnace lead is then converted and refined. Lead production at the smelter varies between 40 000 and 70 000 tonnes a year.
Many employees start work at the smelter between the ages of 20 and 30 and continue their work up to retirement. A duration of employment of 30 to 40 years is therefore not unusual.
Absorbed lead is excreted from the body mainly through the urine and the faeces. The excretion into urine is mostly through glomerular filtration as indicated by experimental animal studies. ' Inorganic lead can affect the human body in several ways. The exposure may disturb haeme synthesis, erythrocyte survival, the nervous system, the gastrointestinal tract, reproduction, and possibly also the cardiovascular system.2
Lead may also cause kidney damage.2" Interstitial nephritis, tubular damage, and at a late stage of the disease, glomerular damage, have also been reported. 35 Functionally, these effects on the kidney may cause leakage of enzymes from tubular cells and excretion of low and high molecular weight proteins into the urine.
Hypertension is a well recognised risk factor in the progression of renal failure. Exposure to lead has been associated with hypertension" even with only modest increases in blood lead concentrations."' Toxicological studies have also documented an association between increased absorption of lead and hypertension. " The effects of lead appear to be mediated through toxic effects on the kidneys and by direct action on vascular smooth muscle. 4 No differences were found in other variables between exposed workers and their corresponding controls. Table 2 presents median values and ranges ofB-Pb concentrations, cumulative blood lead index, and lead concentrations in the calcaneus and tibia. The lead concentrations in bone in active and retired lead workers were significantly higher (p < 0001) than in their corresponding control groups. The retired smelter workers had the highest values. Table 3 gives the median values and ranges of U-Pb, U-albumin, and U-#,-m concentrations and U-NAG activity. Table 4 presents the median values and ranges for P-creatinine concentration, creatinine clearance, albumin clearance, relative albumin clearance (U-albumin x P-creatinine/S-albumin x U-creatinine), 4,-m clearance, and relative #,-m clearance (U-#2-m x P-creatinine/serum-#2-m x U-creatinine). The B-Pb and U-Pb values were significantly higher among active and retired lead workers compared with their corresponding control groups (p < 0001). As expected the highest concentrations were found among the active lead workers. The concentrations of U-albumin and U-f,-m and U-NAG activity among lead workers and controls were within the normal reported ranges. The concentrations of the urinary glomerular (U-albumin, albumin clearance, relative albumin clearance) and tubular (U-#2-m concentration, U-NAG activity, #2-m clearance, relative 12-M clearance) function parameters investigated were of the same magnitude for exposed workers and controls. Accordingly, no signs of clinical renal impairment were found among the workers. It is evident from the blood lead determination that the exposure to lead has decreased considerably at the smelter over the years. From 1950 to 1987 the mean blood lead concentration among lead workers decreased from 3-0 pmol/l to about 1 6 imol/l. For workers exposed to lead at other metal producing plants, the corresponding decrease was from 2-7 to 0 8 imol/l.
It is well known that occupational exposure to lead may effect renal function.232728 The cells lining the proximal tubules appear to be the tissue in the kidney most sensitive to lead.29 At concentrations of lead in blood of around 1-6 pmol/l, lead may partially inhibit the metabolic activation of vitamin D, a transformation that occurs in these cells. 30 Two principal stages of effects of lead on the kidneys have been defined. Stage I is the period of acute effects and is limited to functional and morphological changes in proximal tubular cells. It is manifest clinically as a decrease in energy dependent transport functions, including aminoaciduria, glucosuria, and changes in specific ion transport. The functional changes are thought to be related to an effect on mitochondrial respiration and phosphorylation. The intranuclear inclusion bodies are a characteristic feature of stage I nephropathy. These occur in the cells lining the proximal tubules at blood lead concentrations of 2-4 kimol/l and are composed of lead protein complexes.4'12 They are thought to serve as a protective temporary storage mechanism by which soft tissue lead is incorporated into a non diffusable form, thereby reducing the cytoplasmic concentration of lead available to disrupt essential cell function.5
Stage II is defined as a chronic irreversible condition, characterised by interstitial fibrosis, tubular atrophy, and dilatation and arteriosclerotic changes.35 31 32 Older studies of the effects of lead on kidney function have often used parameters such as concentration of blood urea nitrogen (BUN), serum (S)-creatinine, or total urinary protein concentration as measurements of renal function. Due to the great reserve capacity of the kidney, however, these measures of excretory function can be in the normal range despite considerable impairment of renal function. Blood urea nitrogen and S-creatinine concentrations will increase only when about two thirds of kidney function is lost, and are thus unlikely to detect early or moderate loss of renal function due to lead.
The excretion of low molecular weight proteins in the urine may be a sensitive indicator of early renal injury. Both #2-m and retinol binding protein are freely filtered from the plasma by the renal glomerulus and are taken up by the proximal tubular cells where they are catabolised. The reabsorption of these proteins by the normal kidneys is nearly complete at 99 97% of the filtered load. Thus their concentration in urine is a sensitive index of altered proximal tubular function.33
Another sensitive indicator of renal injury, especially for the detection of possible damage to proximal tubules by lead is multiple enzyme analysis. 34 Activity of N-acetyl-f3-D-glucosaminidase, a lysosomal enzyme present in the brush borders of the proximal tubular cells, has been shown to be raised in urine at the early stages of renal injury, before abnormalities in excretory function take place.32 Thus both U-/32-m concentration and U-NAG activity were chosen as sensitive markers of early tubular damage in our study.
The glomerulus is the main barrier to the renal elimination of high molecular weight (>40 000) proteins. The filtration of proteins by the glomerulus is both size and charge selective. Loss of selectivity of the glomerular filter can be detected early by measurement of the urinary excretion of high molecular weight proteins, predominantly albumin. Other larger proteins such as IgG, IgM, and a2-macroglobulin may also show increased excretion into the urine. In this study albumin was selected as a sensitive indicator of early glomerular damage.
Chronic occupational exposure to lead resulting in concentrations of blood lead exceeding 19 ,umol/l has been associated with subsequent renal disease.35
Other authors"2 " have suggested a higher limit for kidney effects of around 3 ,umol/l. A large proportion of the lead workers in this study have exceeded these limits, especially during the 1950s and 1960s. Thus reversible changes in the tubular function for some workers who were active during these times could not be excluded.
Selevan et al found an excess mortality from chronic renal disease in a cohort study of 1987 men employed in a lead smelter between 1940 and 1965.4'
The risk of death from renal disease increased with increasing duration of employment. In a cohort study of 4519 battery plant workers and 2300 lead production workers, a significant number of excess deaths from chronic nephritis was noted in both cohorts. 41 42 The mean blood lead concentration for 1326 of the battery plant workers with three or more analyses was 3 0 ,umol/l, and 278 had means of 3 4 ,umol/l or more. For 537 lead production workers in four plants the mean was 3 9 ,umol/l. An increased mortality from chronic renal diseases has also been reported in two other cohort studies,43 4 among retired lead battery workers and among lead smelter workers who had received the diagnosis of lead poisoning. In each of these four investigations, a two to threefold increase in deaths from chronic nephritis has been noted.
The smelter workers studied have had a continuous and long term exposure to lead. This is shown by a median cumulative blood lead index of 72-2 pmol/l among the retired lead workers, with corresponding median bone lead concentrations in tibia and calcaneus of 39 3 and 100 2 ,ug/g bone mineral respectively (table 2) . Despite an exposure of this magnitude, however, no signs of adverse effects on the kidney such as early tubular or glomerular damage have been found among the workers in the lead smelter. Similar results have been reported by Buchet et al. 37 Nevertheless, increased urinary excretion of NAG was not found among long term exposed lead smelter workers in our study. The lack of signs of kidney damage among the lead workers in this investigation agrees with earlier reported results from an epidemiological study of mortality from exposure to lead at the same smelter.22 In a cohort of 437 lead smelter workers, two cases of uraemia from kidney diseases that might be caused in part by exposure to lead was in agreement with the expected number of 2-2.
In conclusion, the extent to which low to moderate occupational exposure to lead contributes to lead nephropathy is still debated as published results have been conflicting. Available data from cohorts with long term low exposure to lead are not sufficient to make a proper judgement. Too few studies have been carried out to provide adequate information about the cumulative systemic uptake of lead with time. Because renal changes may be subtle, the number of subjects in the study population must be considered. 
